Aplenzin¿ (bupropion Hydrobromide recalls
The FDA has published 3 recalls involving Aplenzin¿ (bupropion Hydrobromide since 2014. The latest was reported on 5 Nov 2014. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 5 Nov 2014
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 3 100%
Why aplenzin¿ (bupropion hydrobromide is recalled
Companies
By year
All aplenzin¿ (bupropion hydrobromide recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Aplenzin¿ (bupropion hydrobromide) recalled | Valeant Pharmaceuticals North America | Packaging Defects | Nationwide |
| Drug | CLASS III | Aplenzin¿ (bupropion hydrobromide) recalled | Valeant Pharmaceuticals North America | Packaging Defects | Nationwide |
| Drug | CLASS III | Aplenzin¿ (bupropion hydrobromide) recalled | Valeant Pharmaceuticals North America | Packaging Defects | Nationwide |
Should you stop taking Aplenzin¿ (bupropion Hydrobromide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.